Tevogen.AI Secures Global Patent for AI-Powered Peptide Prediction, Revolutionizing Immunotherapy
2025-07-18
The Manila Times
Manila, Philippines – Tevogen.AI (Nasdaq: TVGN), a pioneering biotechnology company leveraging artificial intelligence to accelerate drug discovery, has announced a significant milestone: the publication of its international patent application by the ...Read more
![Albert Lea's New Landscaping Hub: [Business Name] Brings Cutting-Edge Tech & Expert Design to Your Backyard](https://www.albertleatribune.com/wp-content/uploads/sites/14/2025/07/0716daltonlandscaping01.jpg)
